LetterLetter
Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 Antibodies
ERIKA DARRAH, LAURA MARTINEZ-PRAT and MICHAEL MAHLER
The Journal of Rheumatology March 2019, 46 (3) 329-330; DOI: https://doi.org/10.3899/jrheum.180905
ERIKA DARRAH
Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
ED, PhDLAURA MARTINEZ-PRAT
Research and Development, Inova Diagnostics Inc.;
LM-P, BSMICHAEL MAHLER
Research and Development, Inova Diagnostics Inc., San Diego, California,
USA.
MM, PhDREFERENCES
- 1.↵
- 2.↵
- Guderud K,
- Mæhlen MT,
- Nordang GB,
- Viken MK,
- Andreassen BK,
- Molberg Ø,
- et al.
- 3.↵
- Mahler M
- 4.↵
- Darrah E,
- Giles JT,
- Ols ML,
- Bull HG,
- Andrade F,
- Rosen A
- 5.↵
- Halvorsen EH,
- Pollmann S,
- Gilboe IM,
- van der Heijde D,
- Landewe R,
- Odegard S,
- et al.
- 6.↵
- Zhao J,
- Zhao Y,
- He J,
- Jia R,
- Li Z
- 7.↵
- 8.↵
- Navarro-Millan I,
- Darrah E,
- Westfall AO,
- Mikuls TR,
- Reynolds RJ,
- Danila MI,
- et al.
- 9.↵
- Reyes-Castillo Z,
- Palafox-Sanchez CA,
- Parra-Rojas I,
- Martinez-Bonilla GE,
- del Toro-Arreola S,
- Ramirez-Duenas MG,
- et al.
- 10.↵
- Ren J,
- Sun L,
- Zhao J
In this issue
The Journal of Rheumatology
Vol. 46, Issue 3
1 Mar 2019
Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 Antibodies
ERIKA DARRAH, LAURA MARTINEZ-PRAT, MICHAEL MAHLER
The Journal of Rheumatology Mar 2019, 46 (3) 329-330; DOI: 10.3899/jrheum.180905